HUAREN MEDICAL TECHNOLOGY
NEWS
04
2023-09
On August 31st, Zeng Yong, President of Guangxi Huaren Medical Technology Group, warmly received more than 50 trainees of "Guangxi University College of Continuing Education 2023 Yufeng District Committee Management Cadres Learning and Implementing the Party's Twentieth Thematic Training Class (Accelerating the Promotion of Industrial Revitalisation)" who came to visit and study in the Joint Experimental Centre.
View More25
2023-08
Principles of Transdermal Cell Therapy - TCR-T
Recently, Cell Reports Medicine, an internationally renowned journal, released the Phase I clinical research results of TAEST16001, the first TCR-T therapy product in China [1].TAEST16001 is used for the treatment of advanced soft-tissue sarcoma, which is a key step towards the clinical translation of ACT in the field of solid tumours, and once again ignited people's confidence in the treatment of solid tumours with TCR-T therapies. confidence in TCR-T therapy for solid tumours. In this issue, let's talk about the ins and outs of TCR-T therapy.
View More23
2023-08
Guangxi Zhuang Autonomous Region Key Laboratory is an important part of the scientific and technological innovation system of Guangxi, is an important scientific and technological innovation base and main force to organise and carry out high-level basic research and applied basic research, gather and cultivate excellent scientific and technological talents, carry out high-level academic exchanges, and promote the opening up and sharing of scientific and technological resources, and its main task is to focus on the solution of the frontier of the development of academic disciplines and the autonomous region of the national economy and the development of the society of the important scientific issues, to improve the capacity of Guangxi to sustainably innovate, and to carry out innovative researches for the autonomous region of the superiority of the disciplines and the superiority of the economic development.
View More16
2023-08
Principles of Cellular Immunotherapy - CAR-T
In the past decades, scientific research on the anti-tumour mechanism of immune cells has made rapid development, and Adoptive Cell Therapy (ACT) has become the most promising method to cure cancer.ACT therapy refers to the method of collecting the patient's blood, isolating the immune cells in vitro, and infusing them back into the patient's body through modification, proliferation, cultivation, and identification to achieve the purpose of treating cancer. ACT therapy mainly includes TILs, CAR-T, TCR-T, etc. CAR-T (Chimeric Antibody Therapy) is the most promising method to treat cancer.
View More14
2023-08
Micro- and nanorobotics applied to the targeted transport of stem cells
With the rapid development of robotics technology, robots are more and more widely used in daily life, and they are also of great significance to the development and progress of society. With the development of nanotechnology, micro/nanorobot (micro/nanorobot) has gradually become a hotspot for research, and they can operate at the micron or even nanometer scale. Due to the small size of these robots, which are only at the micron or nano level, they can enter into more confined spaces and can also form clusters to work together to accomplish specific tasks.
View More10
2023-08
New hydrogel induces endometrial regeneration
According to the data of "China Infertility Status Survey Report", the number of infertility patients in China has been increasing year by year, and by 2023 it will have exceeded 50 million, accounting for 12.5-15% of the population of childbearing age. Infertility refers to the situation that couples who have been living together for more than 1 year, have normal sex life and do not have any contraceptive measures, but still fail to get pregnant, which seriously affects the couple's relationship and family harmony [1]. Endometrial abnormality is one of the important factors leading to female infertility.
View MoreSUBSCRIPTION INFORMATION
We will send you real-time information regularly!
Guangxi Huaren Medical Technology Group Co., Ltd.
Tel: 400-138-8669/ 0771-611-0603
Address: 15th Floor, Building A, Biyuan Center, Wuxiang New District, Nanning City, China (Guangxi) Pilot Free Trade Zone
Huaren Medical Technology
Huaren Medical Research
Hua Ren Cell said